Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Martijn D. Steenwijk"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Cortical multiple sclerosis lesions are disease-specific, yet inconspicuous on magnetic resonance images (MRI). Double inversion recovery (DIR) images are sensitive, but often unavailable in clinical routine and clinical trials. Artificially
Externí odkaz:
https://doaj.org/article/b92fb9d1baf74d7fa74d78f65d9a8bf4
Autor:
Jens P.E. Schouten, Samantha Noteboom, Roland M. Martens, Steven W. Mes, C. René Leemans, Pim de Graaf, Martijn D. Steenwijk
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Accurate segmentation of head and neck squamous cell cancer (HNSCC) is important for radiotherapy treatment planning. Manual segmentation of these tumors is time-consuming and vulnerable to inconsistencies between experts, especia
Externí odkaz:
https://doaj.org/article/e82ca59eca08469a8047d94dd7b0f328
Autor:
Victor I. J. Strijbis, Christiaan M. de Bloeme, Robin W. Jansen, Hamza Kebiri, Huu-Giao Nguyen, Marcus C. de Jong, Annette C. Moll, Merixtell Bach-Cuadra, Pim de Graaf, Martijn D. Steenwijk
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract In retinoblastoma, accurate segmentation of ocular structure and tumor tissue is important when working towards personalized treatment. This retrospective study serves to evaluate the performance of multi-view convolutional neural networks (
Externí odkaz:
https://doaj.org/article/64b6ff5d7bb04de6a7e9bf1f87dd6bd2
Autor:
Arjan Malekzadeh, Cyra Leurs, Wessel vanWieringen, Martijn D. Steenwijk, Menno M. Schoonheim, Michael Amann, Yvonne Naegelin, Jens Kuhle, Joep Killestein, Charlotte E. Teunissen
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 6, Iss 9, Pp 1582-1594 (2019)
Abstract Background The pathophysiology of multiple sclerosis disease progression remains undetermined. The aim of this study was to identify differences in plasma proteome during different stages of MS disease progression. Methods We used a multiple
Externí odkaz:
https://doaj.org/article/2dcba6eb08e94bdeb938fb2fc1264d0b
Autor:
Floris B. Tijhuis, Tommy A.A. Broeders, Fernando A.N. Santos, Menno M. Schoonheim, Joep Killestein, Cyra E. Leurs, Quinten van Geest, Martijn D. Steenwijk, Jeroen J.G. Geurts, Hanneke E. Hulst, Linda Douw
Publikováno v:
NeuroImage: Clinical, Vol 29, Iss , Pp 102556- (2021)
Background: More than 80% of multiple sclerosis (MS) patients experience symptoms of fatigue. MS-related fatigue is only partly explained by structural (lesions and atrophy) and functional (brain activation and conventional static functional connecti
Externí odkaz:
https://doaj.org/article/8d20c66e6338421eb9b796494a7f8835
Autor:
Marloes H. J. Hagens, Sandeep V. Golla, Martijn T. Wijburg, Maqsood Yaqub, Dennis Heijtel, Martijn D. Steenwijk, Patrick Schober, John J. P. Brevé, Robert C. Schuit, Tristan A. Reekie, Michael Kassiou, Anne-Marie van Dam, Albert D. Windhorst, Joep Killestein, Frederik Barkhof, Bart N. M. van Berckel, Adriaan A. Lammertsma
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-10 (2018)
Abstract Background Over the past decades, positron emission tomography (PET) imaging has become an increasingly useful research modality in the field of multiple sclerosis (MS) research, as PET can visualise molecular processes, such as neuroinflamm
Externí odkaz:
https://doaj.org/article/2093b350138a428a80c3cf2c7276144c
Autor:
Martijn D. Steenwijk, Houshang Amiri, Menno M. Schoonheim, Alexandra de Sitter, Frederik Barkhof, Petra J.W. Pouwels, Hugo Vrenken
Publikováno v:
NeuroImage: Clinical, Vol 15, Iss , Pp 843-853 (2017)
Introduction: Despite the recognized importance of atrophy in multiple sclerosis (MS), methods for its quantification have been mostly restricted to the research domain. Recently, a CE labelled and FDA approved MS-specific atrophy quantification meth
Externí odkaz:
https://doaj.org/article/ff5413c9c9094476a70a41a524046e53
Autor:
Saurabh Jain, Diana M. Sima, Annemie Ribbens, Melissa Cambron, Anke Maertens, Wim Van Hecke, Johan De Mey, Frederik Barkhof, Martijn D. Steenwijk, Marita Daams, Frederik Maes, Sabine Van Huffel, Hugo Vrenken, Dirk Smeets
Publikováno v:
NeuroImage: Clinical, Vol 8, Iss C, Pp 367-375 (2015)
The location and extent of white matter lesions on magnetic resonance imaging (MRI) are important criteria for diagnosis, follow-up and prognosis of multiple sclerosis (MS). Clinical trials have shown that quantitative values, such as lesion volumes,
Externí odkaz:
https://doaj.org/article/43536587431c4edea989fe48660190a6
Publikováno v:
Dementia & Neuropsychologia, Vol 10, Iss 1, Pp 2-11
Cognitive decline is a frequent but undervalued aspect of multiple sclerosis (MS). Currently, it remains unclear what the strongest determinants of cognitive dysfunction are, with grey matter damage most directly related to cognitive impairment. Mult
Externí odkaz:
https://doaj.org/article/8e5d5f1d6cdb44c2b183a9fc3f5e130d
Autor:
Zoë YGJ van Lierop, Samantha Noteboom, Martijn D Steenwijk, Maureen van Dam, Alyssa A Toorop, Zoé LE van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard MJ Uitdehaag, Menno M Schoonheim, Charlotte E Teunissen, Joep Killestein
Publikováno v:
Multiple Sclerosis Journal, 28(14), 2231-2242. SAGE Publications Ltd
van Lierop, Z Y GJ, Noteboom, S, Steenwijk, M D, van Dam, M, Toorop, A A, van Kempen, Z L E, Moraal, B, Barkhof, F, Uitdehaag, B M J, Schoonheim, M M, Teunissen, C E & Killestein, J 2022, ' Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2231-2242 . https://doi.org/10.1177/13524585221118676
van Lierop, Z Y GJ, Noteboom, S, Steenwijk, M D, van Dam, M, Toorop, A A, van Kempen, Z L E, Moraal, B, Barkhof, F, Uitdehaag, B M J, Schoonheim, M M, Teunissen, C E & Killestein, J 2022, ' Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2231-2242 . https://doi.org/10.1177/13524585221118676
Background: Despite highly effective treatment strategies for patients with relapsing-remitting multiple sclerosis (RRMS), long-term neurodegeneration and disease progression are often considerable. Accurate blood-based biomarkers that predict long-t